Copaxone's effect on MRI-monitored disease in relapsing MS is reproducible and sustained. - Wolinsky,J.S.; Comi,G.; Filippi,M.; Ladkani,D.; Kadosh,S.; Shifroni,G. (Neurology, 2002)